SIGA
SIGA Technologies Inc · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website iga.com
- Employees(FY) 39
- ISIN US8269171067
Performance
-1.81%
1W
-14.78%
1M
+58.39%
3M
+59.63%
6M
+45.66%
YTD
+45.92%
1Y
Profile
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Technical Analysis of SIGA 2024-05-10
Overview:
In analyzing the technical indicators for SIGA over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-05-10 09:40
- 2024-05-10 06:40
- 2024-05-09 21:40
- 2024-05-08 09:05
- 2024-05-08 06:45
Q1 2024 SIGA Technologies Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-05-07 21:05
- 2024-05-07 16:05
- 2024-05-07 04:05
- 2024-05-03 12:00
- 2024-05-03 04:51
- 2024-05-03 00:00
- 2024-05-02 17:45
- 2024-05-02 05:45
- 2024-05-01 17:00
- 2024-05-01 05:00
- 2024-04-25 17:45
- 2024-04-25 05:45
- 2024-04-24 06:51
- 2024-04-19 17:45
- 2024-04-19 05:45
- 2024-04-15 17:50
- 2024-04-12 10:00
- 2024-04-12 07:29
- 2024-04-12 06:33
- 2024-04-10 10:00
- 2024-04-02 10:00
- 2024-04-02 07:05
- 2024-04-01 16:05
- 2024-04-01 04:05
- 2024-03-25 07:30
SIGA Names Larry Miller General Counsel(GlobeNewswire)
Page 1 of 5
previousnext